Skip to main content

Search

By Susan Morse | 11:24 am | April 03, 2026
Exemptions include generic drugs and companies that have committed to building manufacturing plants in the United States.
By Susan Morse | 11:09 am | January 02, 2026
HHS has appealed and has been joined by several pharmaceutical companies that want intervenor status.
By Susan Morse | 10:48 am | October 02, 2025
The deal with Pfizer will reduce the price of the company’s prescription drugs for Medicaid to Most Favored Nation pricing.
By Susan Morse | 11:18 am | September 29, 2025
The president says he will impose the tariffs on non-generic drugs unless manufacturers build plants in America.
By Jeff Lagasse | 01:14 pm | May 27, 2025
The MAHA Commission says more rigorous clinical trials are needed for children's vaccines, while PhRMA defends current practices.
By Susan Morse | 10:57 am | February 14, 2025
The American Medical Association has remained relatively silent.
By Jeff Lagasse | 12:04 pm | January 17, 2025
At the top of the list are the popular semaglutides for weight loss, Ozempic, Rybelsus and Wegovy.
By Susan Morse | 11:10 pm | November 14, 2024
The president-elect says his nominee will help protect Americans from "pollutants, pesticides, pharmaceutical products and food additives."
By Susan Morse | 12:13 pm | November 07, 2024
The expectation is for a new Congress to create policy around AI and cybersecurity, says Tom Leary of HIMSS.
By Jeff Lagasse | 10:47 am | August 15, 2024
CMS said that if the new prices had been in effect last year, Medicare would have saved an estimated $6 billion across the 10 drugs.